Market research
4570.TSE Immuno-Biological Laboratories Co., Ltd
TSE JPY Healthcare
Latest close
As of 28 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 9B
- P/E ratio
- 25.36
- Analyst target
- Not available
- Dividend yield
- 0.6%
- Beta
- -0.06
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- JP3921300004
- Market cap
- 9B
- P/E ratio
- 25.36
- Analyst target
- Not available
- Dividend yield
- 0.6%
- Beta
- -0.06
About
About Immuno-Biological Laboratories Co., Ltd
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents internationally. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and supports research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA test kits, antibodies, synthetic peptides, cell culture-related reagents, and contract services such as antibody preparation, purification and labeling, protein production by cell culture, and development of antibody-based measurement systems. It also provides LipoSEARCH, a customized service for profiling and analyzing lipoprotein through gel-filtration, a high-performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for a broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for lifestyle-related diseases. Further, it operates a protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other protein production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Research context
Immuno-Biological Laboratories Co., Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 4570.TSE discussion.
5 years, 6 months ago
Immuno-Biological Laboratories Co., Ltd is currently in a long term downtrend where the price is trading 5.7% below its 200 day moving average.
From a valuation standpoint, the stock is 88.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
Immuno-Biological Laboratories Co., Ltd's total revenue rose by 4.8% to $167M since the same quarter in the previous year.
Its net income has increased by 11.6% to $-73M since the same quarter in the previous year.
Based on the above factors, Immuno-Biological Laboratories Co., Ltd gets an overall score of 3/5.